If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Field Medical Excellence
Download FREE Excerpt
10 Info Graphics
19 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
To maximize the impact of immunology-focused field-based medical teams in high-potential global markets, organizations need to be engaging Thought Leaders effectively and efficiently. Complicating an already difficult assignment, field teams must reflect the needs and opportunities of the region they work in.
Best Practices, LLC conducted this study to provide current immunology field team engagement practices in key markets. The study contains benchmarks around the duration and frequency of MSL and HOL interactions; the degree of proactive vs. reactive interactions; and the time spent on internal and external activities
This study will help companies fill knowledge gaps around MSL engagement trends for immunology-focused field medical teams. Leaders involved with field-based medical teams focused on immunology can utilize this study to compare their engagement approaches and metrics with peers in key markets.
This study includes four segments: All Participants, North America, Europe (Germany and UK), and global (countries outside the US).
Thought Leader Interaction Time & Frequency:
Best Practices, LLC engaged 16 medical affairs and field-based medical team leaders working in immunology through a benchmarking survey. Eleven leading biopharma companies represented. To provide useful insights for leadership teams, benchmark data is segmented by: Total Benchmark Class, Global (ex-U.S.), North America region and EU5 region. Six deep-dive interviews were conducted with medical affairs leaders, whose insights were provided to enrich the data and add real-world context to the metrics and trends established.
Biotech; Pharmaceutical; Health Care; Chemical; Medical Device
Amgen; Allergopharma; Pfizer; Genentech; Shire; Roche; GlaxoSmithKline ; Janssen; EMD Serono; Merck; UCB Pharma
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.